{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T01:43:40Z","timestamp":1781487820266,"version":"3.54.1"},"reference-count":42,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010731","name":"Chiang Mai University Faculty of Medicine","doi-asserted-by":"publisher","award":["141-66"],"award-info":[{"award-number":["141-66"]}],"id":[{"id":"10.13039\/501100010731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002842","name":"Chiang Mai University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002842","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["N42A660301"],"award-info":[{"award-number":["N42A660301"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["N42A660432"],"award-info":[{"award-number":["N42A660432"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["N42A670594"],"award-info":[{"award-number":["N42A670594"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.bbadis.2025.167809","type":"journal-article","created":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T09:13:13Z","timestamp":1742807593000},"page":"167809","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Sodium-glucose cotransporter 2 inhibitor partially improves brain mitochondrial function, but does not mitigate cognitive impairment in rats with myocardial infarction"],"prefix":"10.1016","volume":"1871","author":[{"given":"Nattayaporn","family":"Apaijai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanawat","family":"Attachaipanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chayodom","family":"Maneechote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiranya","family":"Pintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanisa","family":"Thonusin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Titikorn","family":"Chunchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patcharapong","family":"Pantiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Busarin","family":"Arunsak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aphisek","family":"Kongkaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nipon","family":"Chattipakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siriporn C.","family":"Chattipakorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2025.167809_bb0005","first-page":"316","article-title":"Cognitive impairment in heart failure patients","volume":"11","author":"Leto","year":"2014","journal-title":"J Geriatr Cardiol."},{"key":"10.1016\/j.bbadis.2025.167809_bb0010","first-page":"106","article-title":"Expert opinion-cognitive decline in heart failure: more attention is needed","volume":"2","author":"Celutkiene","year":"2016","journal-title":"Card Fail Rev."},{"key":"10.1016\/j.bbadis.2025.167809_bb0015","article-title":"Cognitive impairment in heart failure: landscape, challenges, and future directions","volume":"8","author":"Yang","year":"2021","journal-title":"Front Cardiovasc Med."},{"key":"10.1016\/j.bbadis.2025.167809_bb0020","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13642","article-title":"Cognitive impairment in myocardial infarction and heart failure","volume":"232","author":"Jinawong","year":"2021","journal-title":"Acta Physiol (Oxf)."},{"key":"10.1016\/j.bbadis.2025.167809_bb0025","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1161\/HYPERTENSIONAHA.123.21070","article-title":"Angiotensin II-mediated neuroinflammation in the hippocampus contributes to neuronal deficits and cognitive impairment in heart failure rats","volume":"80","author":"Althammer","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.bbadis.2025.167809_bb0030","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2017.11.024","article-title":"Myocardial inflammation predicts remodeling and neuroinflammation after myocardial infarction","volume":"71","author":"Thackeray","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.bbadis.2025.167809_bb0035","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.jacc.2022.08.801","article-title":"Neurometabolism and ventricular dyssynchrony in patients with heart failure and reduced ejection fraction","volume":"80","author":"Bai","year":"2022","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.bbadis.2025.167809_bb0040","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25052513","article-title":"Cerebral glucose metabolism following tbi: changes in plasma glucose, glucose transport and alternative pathways of glycolysis-a translational narrative review","volume":"25","author":"Gribnau","year":"2024","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.bbadis.2025.167809_bb0045","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2174\/1570159X22666240131114913","article-title":"Modulating mitochondrial dynamics mitigates cognitive impairment in rats with myocardial infarction","volume":"22","author":"Jinawong","year":"2024","journal-title":"Curr Neuropharmacol."},{"key":"10.1016\/j.bbadis.2025.167809_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2023.166809","article-title":"Treatment with apoptosis inhibitor restores cognitive impairment in rats with myocardial infarction","volume":"1869","author":"Jinawong","year":"2023","journal-title":"Biochim Biophys Acta Mol Basis Dis."},{"key":"10.1016\/j.bbadis.2025.167809_bb0055","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bbadis.2025.167809_bb0060","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bbadis.2025.167809_bb0065","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med."},{"key":"10.1016\/j.bbadis.2025.167809_bb0070","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.2337\/dc21-2434","article-title":"Empagliflozin improves cognitive impairment in frail older adults with type 2 diabetes and heart failure with preserved ejection fraction","volume":"45","author":"Mone","year":"2022","journal-title":"Diabetes Care."},{"key":"10.1016\/j.bbadis.2025.167809_bb0075","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12082814","article-title":"Cerebrovascular, cognitive and cardiac benefits of sglt2 inhibitors therapy in patients with atrial fibrillation and type 2 diabetes mellitus: results from a global federated health network analysis","volume":"12","author":"Proietti","year":"2023","journal-title":"J Clin Med."},{"key":"10.1016\/j.bbadis.2025.167809_bb0080","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1007\/s10787-022-00973-5","article-title":"Dapagliflozin as an autophagic enhancer via LKB1\/AMPK\/SIRT1 pathway in ovariectomized\/D-galactose Alzheimer's rat model","volume":"30","author":"Ibrahim","year":"2022","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.bbadis.2025.167809_bb0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.brainresbull.2022.01.017","article-title":"Dapagliflozin diminishes memory and cognition impairment in Streptozotocin induced diabetes through its effect on Wnt\/beta-Catenin and CREB pathway","volume":"181","author":"El-Safty","year":"2022","journal-title":"Brain Res Bull."},{"key":"10.1016\/j.bbadis.2025.167809_bb0090","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.taap.2017.08.005","article-title":"SGLT2-inhibitor and DPP-4 inhibitor improve brain function via attenuating mitochondrial dysfunction, insulin resistance, inflammation, and apoptosis in HFD-induced obese rats","volume":"333","author":"Sa-Nguanmoo","year":"2017","journal-title":"Toxicol Appl Pharmacol."},{"key":"10.1016\/j.bbadis.2025.167809_bb0095","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1007\/s00259-020-04736-8","article-title":"Angiotensin-converting enzyme inhibitor treatment early after myocardial infarction attenuates acute cardiac and neuroinflammation without effect on chronic neuroinflammation","volume":"47","author":"Borchert","year":"2020","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"10.1016\/j.bbadis.2025.167809_bb0100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1530\/JOE-21-0134","article-title":"Necrostatin-1 reduces cardiac and mitochondrial dysfunction in prediabetic rats","volume":"251","author":"Apaijai","year":"2021","journal-title":"J Endocrinol."},{"key":"10.1016\/j.bbadis.2025.167809_bb0105","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.2337\/db19-1128","article-title":"Necrostatin-1 mitigates cognitive dysfunction in prediabetic rats with no alteration in insulin sensitivity","volume":"69","author":"Jinawong","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2025.167809_bb0110","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.chroma.2017.09.023","article-title":"Evaluation of intensity drift correction strategies using MetaboDrift, a normalization tool for multi-batch metabolomics data","volume":"1523","author":"Thonusin","year":"2017","journal-title":"J Chromatogr A."},{"key":"10.1016\/j.bbadis.2025.167809_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/jnr.25389","article-title":"The comparative effects between long-term and short-term treatment of finasteride on anxiety-like and depression-like behaviors in early senescent male rats","volume":"102","author":"Pintana","year":"2024","journal-title":"J Neurosci Res."},{"key":"10.1016\/j.bbadis.2025.167809_bb0120","doi-asserted-by":"crossref","first-page":"e2","DOI":"10.1093\/eurheartj\/ehx365","article-title":"Cognitive changes in prevalent and incident cardiovascular disease: a 12-year follow-up in the Maastricht Aging Study (MAAS)","volume":"43","author":"Schievink","year":"2022","journal-title":"Eur Heart J."},{"key":"10.1016\/j.bbadis.2025.167809_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104384","article-title":"Restoring myocardial infarction-induced long-term memory impairment by targeting the cystic fibrosis transmembrane regulator","volume":"86","author":"Vanherle","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bbadis.2025.167809_bb0130","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.001920","article-title":"Tumor necrosis factor-alpha underlies loss of cortical dendritic spine density in a mouse model of congestive heart failure","volume":"4","author":"Meissner","year":"2015","journal-title":"J Am Heart Assoc."},{"key":"10.1016\/j.bbadis.2025.167809_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0063829","article-title":"Increases in the risk of cognitive impairment and alterations of cerebral beta-amyloid metabolism in mouse model of heart failure","volume":"8","author":"Hong","year":"2013","journal-title":"PLoS One."},{"key":"10.1016\/j.bbadis.2025.167809_bb0140","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.ynstr.2018.05.003","article-title":"Chronic stress as a risk factor for Alzheimer's disease: roles of microglia-mediated synaptic remodeling, inflammation, and oxidative stress","volume":"9","author":"Bisht","year":"2018","journal-title":"Neurobiol Stress"},{"key":"10.1016\/j.bbadis.2025.167809_bb0145","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.freeradbiomed.2017.11.006","article-title":"Implications of disturbances in circadian rhythms for cardiovascular health: a new frontier in free radical biology","volume":"119","author":"Khaper","year":"2018","journal-title":"Free Radic Biol Med."},{"key":"10.1016\/j.bbadis.2025.167809_bb0150","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.mito.2021.06.008","article-title":"Chronic treatment with dapagliflozin protects against mitochondrial dysfunction in the liver of C57BL\/6NCrl mice with high-fat diet\/streptozotocin-induced diabetes mellitus","volume":"59","author":"Belosludtsev","year":"2021","journal-title":"Mitochondrion"},{"key":"10.1016\/j.bbadis.2025.167809_bb0155","first-page":"439","article-title":"The role of caspase-dependent and caspase-independent pathways of apoptosis in the premature rupture of the membranes: a case-control study","volume":"18","author":"Negara","year":"2020","journal-title":"Int J Reprod Biomed."},{"key":"10.1016\/j.bbadis.2025.167809_bb0160","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1038\/sj.cdd.4400944","article-title":"Endonuclease G: a mitochondrial protein released in apoptosis and involved in caspase-independent DNA degradation","volume":"8","author":"van Loo","year":"2001","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bbadis.2025.167809_bb0165","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/35083620","article-title":"Endonuclease G is an apoptotic DNase when released from mitochondria","volume":"412","author":"Li","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2025.167809_bb0170","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/S0959-4388(98)80062-7","article-title":"Molecular mechanisms of glutamate receptor clustering at excitatory synapses","volume":"8","author":"O'Brien","year":"1998","journal-title":"Curr Opin Neurobiol."},{"key":"10.1016\/j.bbadis.2025.167809_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/cells11213372","article-title":"Empagliflozin induced ketosis, upregulated igf-1\/insulin receptors and the canonical insulin signaling pathway in neurons, and decreased the excitatory neurotransmitter glutamate in the brain of non-diabetics","volume":"11","author":"Avgerinos","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.bbadis.2025.167809_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanhl.2024.08.001","article-title":"SGLT2 inhibitors and GLP-1 receptor agonists: which is the best anti-frailty drug?","volume":"5","author":"Mone","year":"2024","journal-title":"Lancet Healthy Longev."},{"key":"10.1016\/j.bbadis.2025.167809_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanhl.2024.07.004","article-title":"Effect of frailty on effectiveness and safety of GLP-1 receptor agonists versus SGLT2 inhibitors in people with type 2 diabetes in Taiwan: a retrospective, nationwide, longitudinal study","volume":"5","author":"Hsiao","year":"2024","journal-title":"Lancet Healthy Longev."},{"key":"10.1016\/j.bbadis.2025.167809_bb0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2024.106709","article-title":"A timeline study on vascular co-morbidity induced cerebral endothelial dysfunction assessed by perfusion MRI","volume":"202","author":"Callewaert","year":"2024","journal-title":"Neurobiol Dis."},{"key":"10.1016\/j.bbadis.2025.167809_bb0195","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1536\/ihj.17-610","article-title":"Endothelial dysfunction is associated with cognitive impairment of elderly cardiovascular disease patients","volume":"59","author":"Fujiyoshi","year":"2018","journal-title":"Int Heart J."},{"key":"10.1016\/j.bbadis.2025.167809_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/biom14060721","article-title":"Endothelial dysfunction and pre-existing cognitive disorders in stroke patients","volume":"14","author":"Mendyk-Bordet","year":"2024","journal-title":"Biomolecules"},{"key":"10.1016\/j.bbadis.2025.167809_bb0205","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1161\/HYPERTENSIONAHA.122.19586","article-title":"SGLT2 inhibition via empagliflozin improves endothelial function and reduces mitochondrial oxidative stress: insights from frail hypertensive and diabetic patients","volume":"79","author":"Mone","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.bbadis.2025.167809_bb0210","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.2337\/dc23-0671","article-title":"Comparative cardiovascular effectiveness and safety of SGLT-2 Inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors according to frailty in type 2 diabetes","volume":"46","author":"Kutz","year":"2023","journal-title":"Diabetes Care."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925001541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443925001541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T12:34:29Z","timestamp":1749558869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443925001541"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S0925443925001541"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167809","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium-glucose cotransporter 2 inhibitor partially improves brain mitochondrial function, but does not mitigate cognitive impairment in rats with myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2025.167809","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"167809"}}